These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1113 related items for PubMed ID: 30507073

  • 1. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
    Vandelli L, Marietta M, Trenti T, Varani M, Bigliardi G, Rosafio F, Dell'acqua ML, Picchetto L, Nichelli P, Zini A.
    Adv Clin Exp Med; 2019 Feb; 28(2):219-222. PubMed ID: 30507073
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L, Marietta M, Gambini M, Cavazzuti M, Trenti T, Cenci MA, Casoni F, Bigliardi G, Pentore R, Nichelli P, Zini A.
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [Abstract] [Full Text] [Related]

  • 3. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T, Hanumanthu R, Khandelwal P.
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [Abstract] [Full Text] [Related]

  • 4. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J, Shen X, Han C, Mei C, Zhou Y, Wang H, Kong Y, Jiang Y, Fang Q, Cai X.
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [Abstract] [Full Text] [Related]

  • 5. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ, Chen CH, Yeh SJ, Tsai LK, Tang SC, Jeng JS.
    Cerebrovasc Dis; 2016 Nov; 42(1-2):117-21. PubMed ID: 27088493
    [Abstract] [Full Text] [Related]

  • 6. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
    IMS Study Investigators.
    Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018
    [Abstract] [Full Text] [Related]

  • 7. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC, Rabinstein AA.
    Cerebrovasc Dis; 2012 Apr; 34(2):106-14. PubMed ID: 22868870
    [Abstract] [Full Text] [Related]

  • 8. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA, Hurley D, Song J, Sajeev G, Guo J, Du EX, Paschoalin M, Wu EQ.
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [Abstract] [Full Text] [Related]

  • 9. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH, Kim BJ, Han MK, Park TH, Lee KB, Lee BC, Yu KH, Oh MS, Cha JK, Kim DH, Nah HW, Lee J, Lee SJ, Ko Y, Kim JG, Park JM, Kang K, Cho YJ, Hong KS, Choi JC, Kim JT, Choi K, Kim DE, Ryu WS, Kim WJ, Shin DI, Yeo M, Lee J, Lee JS, Gorelick PB, Bae HJ.
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [Abstract] [Full Text] [Related]

  • 10. Leukoaraiosis, Cerebral Hemorrhage, and Outcome After Intravenous Thrombolysis for Acute Ischemic Stroke: A Meta-Analysis (v1).
    Charidimou A, Pasi M, Fiorelli M, Shams S, von Kummer R, Pantoni L, Rost N.
    Stroke; 2016 Sep; 47(9):2364-72. PubMed ID: 27491738
    [Abstract] [Full Text] [Related]

  • 11. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S, Hosomi N, Sueda Y, Kono T, Takamatsu K, Ohyama H, Torii T, Kitamura T, Nomura E, Noda K, Ohtsuki T, Matsumoto M, HARP Registry Study Group.
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [Abstract] [Full Text] [Related]

  • 12. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 13. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J, Sabovic M, Frol S.
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [Abstract] [Full Text] [Related]

  • 14. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M, Wang-Qin RQ, Wang YL, Liu LB, Pan YS, Liao XL, Wang YJ, Xu AD.
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [Abstract] [Full Text] [Related]

  • 15. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y, Liao X, Pan Y, Dong K, Wang Y, Wang Y, Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China) InvestigatorsDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China; Department of Neurology, Baotou Central Hospital, Baotou, Inner Mongolia, China..
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [Abstract] [Full Text] [Related]

  • 16. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW, Tsai YT, Chou PC, Chen HM, Lu CM, Tsao CR, Chen CL, Sun MC, Shih YS, Hsieh CY, Chen LA, Chen PL, Yeh JT, Li YH.
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
    [Abstract] [Full Text] [Related]

  • 17. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T, Suarez JI, Tarr RW, Welter E, Landis D, Sunshine JL, Zaidat OO.
    J Stroke Cerebrovasc Dis; 2008 Mar; 17(3):121-8. PubMed ID: 18436152
    [Abstract] [Full Text] [Related]

  • 18. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
    Adeoye O, Knight WA, Khoury J, Schmit PA, Sucharew H, Broderick JP, Pancioli AM, CLEAR-ER Investigators.
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(5):e313-5. PubMed ID: 24534128
    [Abstract] [Full Text] [Related]

  • 19. Elevated plasma fibrinogen indicates short-term poor outcome in patients with acute ischemic stroke after intravenous thrombolysis.
    Li D, Xing C, Li Y, Zhu X.
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104991. PubMed ID: 32689615
    [Abstract] [Full Text] [Related]

  • 20. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS, Cacayorin ED, Grotta JC, Noser EA.
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.